Home > Insider Trading > Filing (0001209191-15-033129)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1624033	Yao Wenqing	1801 Augustine Cut-Off Wilmington DE 19803	Evp, Discovery Medicinal And P	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-04-07	5,000	$17.79	48,720	No	4	M	Direct
Common Stock	Disposition	2015-04-07	5,000	$90.25	43,720	No	4	S	Direct
Common Stock	Disposition	2015-04-07	1,853	$90.27	41,867	No	4	S	Direct
Common Stock	Disposition	2015-04-07	3,178	$90.22	38,689	No	4	S	Direct
Common Stock	Disposition	2015-04-07	5,000	$90.29	33,689	No	4	S	Direct
Common Stock	Disposition	2015-04-07	5,000	$89.75	28,689	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-04-07	5,000	$0.00	5,000	$17.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,354		2019-01-18	No	4	M	Direct

Footnotes

Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Represents weighted average sale price. Actual sale prices ranged from $89.15- $91.00.
Represents weighted average sale price. Actual sale prices ranged from $89.15- $91.03.
Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.